Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/17534666251362671
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850074663017775104
collection DOAJ
format Article
id doaj-art-c1bcabd935604392affed21742702fba
institution DOAJ
issn 1753-4666
language English
publishDate 2025-07-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Respiratory Disease
spelling doaj-art-c1bcabd935604392affed21742702fba2025-08-20T02:46:29ZengSAGE PublishingTherapeutic Advances in Respiratory Disease1753-46662025-07-011910.1177/17534666251362671Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”https://doi.org/10.1177/17534666251362671
spellingShingle Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”
Therapeutic Advances in Respiratory Disease
title Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”
title_full Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”
title_fullStr Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”
title_full_unstemmed Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”
title_short Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”
title_sort retraction two day versus seven day course of levofloxacin in acute copd exacerbation a randomized controlled trial
url https://doi.org/10.1177/17534666251362671